Publications

5600 Results

TAILORx: Phase III trial of chemoendocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, node negative breast cancer and an intermediate prognosis 21-gene recurrence score

Authors
J Sparano;RJ Gray;W Wood;D Makower;T Lively;T Saphner;M Keane;HL Gomez;PS Reddy;T Goggins;I Mayer;D Toppmeyer;A Brufsky;M Goetz;D Hayes;C Dees;K Pritchard;CE Geyer;JA Olson;GW Sledge
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr LBA1); Annual Meeting (June 1- 5, 2018, Chicago, IL)
Year
2018
Research Committee(s)
Breast

Characterization and predictors of long term (= 10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer patients

Authors
M Friedlander;J Chan;J Java;DK Armstrong;M Markman;S Herzog;B Monk;F Backes;A Secord;A Bonebrake;P Rose;K Tewari;RS Mannel;S Lentz;M Geller;LJ Copeland
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 5556); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gynecologic

Dietary fat intake after colon cancer diagnosis in relation to cancer recurrence and survival

Authors
E Van Blarigan;C Fuchs;F-S Ou;D Niedzwiecki;S Zhang;L Saltz;RJ Mayer;A Hantel;A Venook;S Ogino;M Song;E Giovannucci;J Meyerhardt
Journal / Conference
Cancer Epidemiol Biomarkers Prevention Oct;27(10):1227-1230
Year
2018
Research Committee(s)
Gastrointestinal
PMID
PMID30038051
PMC
PMC6170705
Study Number(s)
C89803

Gonadotropin-releasing hormone analogs during chemotherapy for preservation of ovarian function and fertility in premenopausal early breast cancer patients: a systemic review and meta-analysis of individual patient-level data [Review]

Authors
M Lambertini;H Moore;RC Leonard;S Loibl;P Munster;M Bruzzone;L Boni;J Unger;RA Anderson;K Metha;S Minton;F Poggio;K Albain;DJA Adamson;B Gerber;A Cripps;G Bertelli;S Seiler;M Ceppi;A Partridge;L Del Mastro
Journal / Conference
Journal of Clinical Oncology Jul 1;36(19):1981-1990; May 2:JCO2018780858. doi: 10.1200/JCO.2018.78.0858. [Epub ahead of print]
Year
2018
Research Committee(s)
Breast and Cancer Survivorship
PMID
PMID29718793
PMC
PMC6804855
Study Number(s)
S0230

Rationale, Development, and Design of the Altering Intake, Managing Symptoms (AIMS) Dietary Intervention for Bowel Dysfunction in Rectal Cancer Survivors

Authors
V Sun;T Crane;S Slack;A Yung;S Wright;S Sentovich;K Melstrom;M Fakih;R Krouse
Journal / Conference
Contemporary Clinical Trials May;68:61-66. doi: 10.1016/j.cct.2018.03.010. Epub 2018 Mar 19.
Year
2018
Research Committee(s)
Cancer Survivorship and Symptom Management and Survivorship
PMID
PMID29567283
PMC
PMC5899669

Dietary Modifications for Bowel Dysfunction in Rectal Cancer Survivors: The Altering Intake, Managing Symptoms (AIMS) Intervention Study

Authors
V Sun;TE Crane;S Slack;A Yung;S Wright;S Sentovich;K Melstrom;M Fakih;R Krouse;CA Thomson
Journal / Conference
ASCO Cancer Survivorship Symposium: Advancing Care and Research (February 16-17, 2018, Orlando, FL), abst 141, poster
Year
2018
Research Committee(s)
Cancer Survivorship

Dietary behavior change for bowel symptom management in rectal cancer survivors: the Altering Intake, Managing Symptoms (AIMS) intervention

Authors
V Sun;TE Crane;SD Slack;A Yung;S Wright;R Krouse;CA Thomson
Journal / Conference
ASPO 42nd Annual Conference (Mar 10-13, 2018, New York, NY), poster
Year
2018
Research Committee(s)
Cancer Survivorship

Effect of age, gender, and performance status (PS) on the duration results of adjuvant chemotherapy for stage III colon cancer: The IDEA collaboration

Authors
A Shields;FS Ou;J Paul;A Sobrero;T Yoshino;J Taieb;I Souglakos;Q Shi;R Kerr;R Labianca;T Yamanaka;D Vernerey;I Boukovinas;T Kato;V Torri;S Kakolyris;T Andre;T Grothey;J Meyerhardt;T Iveson
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 3599); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80702

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer

Authors
JK Parsons;JP Pierce;J Mohler;E Paskett;S-H Jung;MJ Morris;E Small;O Hahn;P Humphrey;JR Marshall
Journal / Conference
British Journal of Urology International Apr;121(4):534-539
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID28437029
PMC
PMC5654696
Study Number(s)
CTSU/C70807

Phase 1/2 Trial of GCLAM with Dose-Escalated Mitoxantrone for Newly Diagnosed AML or Other High-Grade Myeloid Neoplasms

Authors
A Halpern;M Othus;E Huebner;BL Scott;P Becker;M Percival;P Hendrie;KM Gardner;TL Chen;S Buckley;KF Orlowski;A Anwar;F Appelbaum;H Erba;E Estey;R Walter
Journal / Conference
Leukemia Nov;32(11):2352-2362; Apr 17 [Epub ahead of print]
Year
2018
Research Committee(s)
Leukemia
PMID
PMID29720734
PMC
PMC6192860
Study Number(s)
S0106